Literature DB >> 5796265

Cerebrospinal fluid 5-hydroxyindoleactiic acid and homovanillic acid in psychiatric patients.

M B Bowers, G R Heninger, F Gerbode.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5796265     DOI: 10.1016/0028-3908(69)90046-x

Source DB:  PubMed          Journal:  Int J Neuropharmacol        ISSN: 0375-9458


× No keyword cloud information.
  20 in total

Review 1.  Antidepressants and serotonergic neurotransmission: an integrative review.

Authors:  P Willner
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

2.  Monoamine metabolite levels in cerebrospinal fluid of psychotic women treated with melperone or thiothixene.

Authors:  L Bjerkenstedt; B Gullberg; C Härnryd; G Sedvall
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1977-10-11

Review 3.  [Biochemistry of depression].

Authors:  N Matussek
Journal:  J Neural Transm       Date:  1972       Impact factor: 3.575

4.  The daily rhythm of HVA, VMA, (VA) and 5-HIAA in depression-syndrome.

Authors:  P Riederer; W Birkmayer; E Neumayer; L Ambrozi; W Linauer
Journal:  J Neural Transm       Date:  1974       Impact factor: 3.575

5.  The tyrosine-tryptophan-diagram in a longtime study with depressed patients.

Authors:  P Riederer; W Birkmayer; E Neumayer
Journal:  J Neural Transm       Date:  1973       Impact factor: 3.575

6.  Relationship of age and mood to monoamine metabolites in cerebrospinal fluid in parkinsonism.

Authors:  A K Granerus; T Magnusson; B E Roos; A Svanborg
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

7.  5-Hydroxyindolacetic acid and homovanillic acid in cerebrospinal fluid in manic-depressive psychosis.

Authors:  R Sjöström; B E Roos
Journal:  Eur J Clin Pharmacol       Date:  1972-06       Impact factor: 2.953

8.  Extrapyramidal side effects and increased serum prolactin following fluoxetine, a new antidepressant.

Authors:  H Y Meltzer; M Young; J Metz; V S Fang; P M Schyve; R C Arora
Journal:  J Neural Transm       Date:  1979       Impact factor: 3.575

9.  Fluvoxamine-a new serotonin re-uptake inhibitor: first clinical and psychometric experiences in depressed patients.

Authors:  B Saletu; M Schjerve; J Grünberger; H Schanda; O H Arnold
Journal:  J Neural Transm       Date:  1977       Impact factor: 3.575

10.  5-hydroxytryptamine and depression: a model for the interaction of normal variance with pathology.

Authors:  F K Goodwin; R M Post
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.